Details for: LABETALOL HYDROCHLORIDE INJECTION USP
Company: PFIZER CANADA ULC
DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
---|---|---|---|---|---|
02391090 | LABETALOL HYDROCHLORIDE INJECTION USP | LABETALOL HYDROCHLORIDE | 5 MG / ML | SOLUTION | INTRAVENOUS |
Consumer Information
This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.
What the medication is used for
Labetalol Hydrochloride Injection USP is used in the hospital for the emergency treatment of very high blood pressure. It is given to you when your blood pressure needs to be lowered quickly.
What it does
Labetalol Hydrochloride Injection USP is a fast acting blood pressure lowering medication that belongs to a group of drugs called “beta-blockers”. They work by:
When it should not be used
What the medicinal ingredient is
labetalol hydrochloride
What the non-medicinal ingredients are
Dextrose anhydrous 45 mg, disodium edetate 0.1 mg; methylparaben 0.08% (w/v) and propylparaben 0.01% (w/v) as preservatives and citric acid monohydrate and/or sodium hydroxide to adjust pH and water for injection.
What dosage form it comes in
Solution for Injection: 5 mg/mL.
Warnings and precautions
To help avoid side effects and ensure proper use, you or your caregiver should talk to
your healthcare professional before you are given Labetalol Hydrochloride Injection
USP. You or your caregiver should talk about any health conditions or problems you
may have, including if you:
Have a history of heart problems.
You or your caregiver should tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.
Interactions with this medication
Proper use of this medication
How Labetalol Hydrochloride Injection USP is given:
You should only be given Labetalol Hydrochloride Injection USP:
Adult dose: Your healthcare professional will decide the best dose for you. It will depend on:
During treatment
After treatment
For elderly patients and patients with liver problems: Smaller doses are generally used in older patients, and those with liver problems.
Overdose:
Side effects and what to do about them
These are not all the possible side effects you may feel when taking Labetalol
Hydrochloride Injection USP. If you experience any side effects not listed here,
contact your healthcare professional. Please also see Warnings and Precautions.
Side effects may include:
Symptom / effect | Talk with your doctor or pharmacist Only if severe | Talk with your doctor or pharmacist In all cases | Stop taking drug and get immediate medical help |
---|---|---|---|
COMMON | |||
|
✔ | ||
|
✔ | ||
UNCOMMON | |||
|
✔ | ||
|
✔ | ||
|
✔ | ||
|
✔ | ||
|
✔ | ||
UNKNOWN FREQUENCY | |||
|
✔ |
If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.
How to store
Labetalol Hydrochloride Injection USP will be stored by your healthcare professional, hospital, or clinic.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/healthcanada/services/drugs-health-products/medeffectcanada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345.
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
If you want more information about Labetalol Hydrochloride Injection USP:
This leaflet was prepared by:
Pfizer Canada ULC.
Kirkland, Québec H9J 2M5
Last revised: May 4, 2020